Clozapine is an atypical antipsychotic medication used in the treatment of schizophrenia, and is also sometimes used off-label for the treatment of bipolar disorder and borderline personality disorder.
We would like to invite you to join guest speaker Dr Dan Siskind from the University of Queensland for a live webinar and explore the use of clozapine in schizophrenia.
Date and time:
Friday 6 November 2015 3:30 PM - 4:00 PM (Sydney Time)
Dr Dan Siskind
Queensland Centre for Mental Health Research
The University of Queensland
Dr Siskind trained as a psychiatrist in Australia and the United States. He graduated MBBS from UQ in 1998. He moved to Boston in 2002, where he did his psychiatry training at Boston University and a Master of Public Health program at Harvard University. He spent two years undertaking research at the Harvard School of Public Health evaluating cost effective treatments for mental illness in developing countries. He returned to Brisbane in June 2008 to take a position as a clinical academic psychiatrist at Metro South Mental Health Service, working with the PAH Mobile Intensive Rehabilitation Team. His PhD thesis with the UQ Queensland Centre for Mental Health Research on “Supported Accommodation for People with Severe and Persistent Mental Illness” was conferred in Feb 2014. His research interests include supported accommodation, international and transcultural mental health, ECT, clozapine, physical health of people living with mental illness, assertive community treatment and mental health services research.
Free, with registration required
Richard He | Program Manager
T +61 2 9845 7798